Get Started

Artificial Intelligence | Machine Learning | Natural Language Processing Ozette | High-Resolution Immune Profiling

Consumer, Enterprise, Immune Profiling, Single-Cell Data, Biotechnology, Diognostic Support System Seattle, Washington, United States

Artificial Intelligence | Machine Learning | Natural Language Processing

Ozette | High-Resolution Immune Profiling

Immune Profiling, Single-Cell Data, Biotechnology, Diognostic Support System

Seattle, Washington, United States

Ozette’s immune profiling platform provides insights that help answer some of the most pressing questions, such as whether or not therapy works for an individual patient or if we can determine a patient’s disease before they have physical manifestations. Answering these critical questions and understanding the complexity of the immune system in health and disease helps us drive towards better patient outcomes—a core motivation for Ozette.

Each year people are diagnosed with cancer, autoimmune diseases, chronic conditions, and more. The immune system is the ultimate determinant of health and disease; however, it remains a black box. Leveraging our immune profiling platform, we want to provide high-resolution understandings of the immune system to fully unlock its power.

Total Funding: N/A

Funding Stage: N/A

Business Stage: Scaling Up

Market: B2C, B2B

Company Size: 1 to 25

Founded: 2021

Date

Round

$ Raised

Investors

07/28/2022

Series A

$26M

Madrona Venture Group, Cercano Management, M12 - Microsoft's Venture Fund, Alexandria Venture Investments, OCV Partners, Duke University

Date : 07/28/2022

Round: Series A

$ Raised: $26M

Investors: Madrona Venture Group, Cercano Management, M12 - Microsoft's Venture Fund, Alexandria Venture Investments, OCV Partners, Duke University

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

Signup and Get Started

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Ozette